FRNM Stock Chart & Stats
$14.09
-$0.02(-0.20%)
At close: 4:00 PM EST
$14.09
-$0.02(-0.20%)
Day’s Range― - ―
52-Week Range$9.95 - $17.18
Previous CloseN/A
VolumeN/A
Average Volume (3M)918.62K
Market Cap
$1.75B
Enterprise Value$123.54M
Total Cash (Recent Filing)$437.37K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding107,446,815
10 Day Avg. Volume875,221
30 Day Avg. Volume918,616
Financial Highlights & Ratios
PEG Ratio-3.08
Price to Book (P/B)1.29
Price to Sales (P/S)0.00
P/FCF Ratio-129.98
Enterprise Value/Market Cap0.07
Enterprise Value/Revenue149.50
Enterprise Value/Gross Profit149.50
Enterprise Value/Ebitda-49.33
Forecast
1Y Price Target
$18.00Price Target Upside27.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-3.95
Revenue Forecast (FY)$95.36M
Freenome Inc News
FRNM FAQ
What was Freenome Inc’s price range in the past 12 months?
Freenome Inc lowest stock price was $9.95 and its highest was $17.18 in the past 12 months.
What is Freenome Inc’s market cap?
Freenome Inc’s market cap is $1.75B.
When is Freenome Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Freenome Inc’s earnings last quarter?
Currently, no data Available
Is Freenome Inc overvalued?
According to Wall Street analysts Freenome Inc’s price is currently Undervalued.
Does Freenome Inc pay dividends?
Freenome Inc does not currently pay dividends.
What is Freenome Inc’s EPS estimate?
Freenome Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Freenome Inc have?
Freenome Inc has 107,446,815 shares outstanding.
What happened to Freenome Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Freenome Inc?
Currently, no hedge funds are holding shares in FRNM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Freenome Inc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.00 (27.75% Upside)
$18.00 (27.75% Upside)
Blogger Sentiment
Bullish
FRNM Sentiment 75%
Sector Average 58%
Sector Average 58%
Hedge Fund Trend
Increased
By 274.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.59%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.10%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Freenome Inc
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
FRNM Stock 12 Month Forecast
Average Price Target
$18.00
▲(27.75% Upside)
Technical Analysis
Ownership Overview
18.25% Insiders
<0.01% Mutual Funds
― Other Institutional Investors
80.99% Public Companies and
Individual Investors